Skip to Content

Budesonide Inhalation Suspension

Last Updated: September 28, 2011
Status: Resolved

Products Affected - Description

Budesonide Inhalation Suspension, Teva

Reason for the Shortage

  • Teva could not provide a reason for the shortage.
  • AstraZeneca states the shortage was due to increased demand.

Estimated Resupply Dates

  • Teva has available budesonide inhalation 0.25 mg/2 mL suspension (NDC 00093-6815-73) and 0.5 mg/2 mL suspension (NDC 00093-6816-73).
  • AstraZeneca has available Pulmicort Respules 1 mg/2 mL suspension (NDC 00186-1990-04), 0.25 mg/2 mL suspension (NDC 00186-1988-04), and 0.5 mg/2 mL suspension (NDC 00186-1989-04).

Related Shortages

Updated

September 28, 2011; September 2, 2011; August 26, 2011; June 28, 2011; June 2, 2011; April 29, 2011; March 24, 2011, University of Utah, Drug Information Service. Copyright 2011, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide